C326, IL-6 Inhibitory Avimer protein ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病1

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00353756
(ClinicalTrials.gov)
September 200617/7/2006Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn’s DiseaseA Placebo-Controlled, Phase 1, Single and Multiple IV Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of C326 in Adults With Crohn’s DiseaseCrohn's DiseaseDrug: C326, IL-6 Inhibitory Avimer proteinAvidiaNULLRecruiting18 Years65 YearsBoth52Phase 1Australia